SAN DIEGO, April 15, 2015 – Profil Institute for Clinical Research, Inc., an early engagement clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today its 11th year as a corporate sponsor of the American Diabetes Association’s (ADA) Tour de Cure and a team of 70 participants fundraising for this event as members of the Profil Peddlers Team.
The Profil Peddler team has raised $35,000 for this year’s Tour de Cure, an increase of more than 50% over the team’s original goal, and that amount is likely to increase before the event this weekend. The team consists of people who have a passion to make a difference in their community and in the lives of people affected by diabetes. Many team members are affected by diabetes themselves or supporting others with diabetes.
“The team’s enthusiasm for fundraising and Profil Institute’s support of its team members is extraordinary. Nearly every day someone is hosting a fundraising effort. Fellow Profil Peddler teammates and Profil employees support those events as if they were immediate family. It’s truly inspiring what a group of individuals can accomplish when supporting an important altruistic cause,” said Kristin Stanley, Profil Peddler Team Captain and employee of Profil Institute.
This year marks Profil Institute’s 11th year as a corporate sponsor of the ADA’s Tour de Cure and organizer of the Profil Peddler Team. Profil Institute also supports and organizes teams for a number of other events, including JDRF’s Walk to Cure Diabetes and ADA’s Step Out Walk to Stop Diabetes, both of which take place in the fall each year.
“Profil Institute is an ardent supporter of the American Diabetes Association and other advocacy groups with a similar mission of advancing research to eradicate diabetes and improving the lives of people with this and related metabolic disorders,” said Marcus Hompesch, Profil Institute’s CEO and a Profil Peddler. “This year in particular I am so proud to stand among the Profil Peddler participants and supporters and the truly impactful and meaningful difference we are making in our community in support of the ADA.”
This year’s Tour de Cure will take place this Saturday, April 18 beginning at the Del Mar Fairgrounds. The Tour de Cure is a series of fundraising cycling events held in 44 states nationwide to support the mission of the ADA to prevent and cure diabetes and to improve the lives of all people affected by the disease. For more information about San Diego’s Tour de Cure to take place on Saturday, April 18, visit the website http://main.diabetes.org/site/TR?fr_id=10152&pg=entry.
About Profil Institute for Clinical Research, Inc.
Profil Institute is an early engagement clinical research organization (CRO) exclusively focused on metabolic diseases, including diabetes, obesity and NAFLD/NASH. It is renowned for its scientific expertise, expanded scope of research methodologies, and experience with every clinically relevant drug class in diabetes. The company provides a full scope of CRO services from consulting for strategic clinical development and regulatory planning through design and completion of complex clinical trials, including the reporting and publication of final study results.
Profil Institute’s expertise and experience encompasses small and large molecule therapies, biologics and biosimilars through all routes of administration, as well as devices. The company’s clients range from large pharma and drug discovery companies to small virtual companies throughout the Americas, Europe and Asia.
Profil Institute is also recognized globally as an innovator of methodologies, including its Automated Glucose Clamp technology, and for driving new, higher standards in metabolic clinical research through collaborative science with key academic and industry partners.
For further information, visit www.profilinstitute.com or contact:
If inquiring about participation in a clinical research study, please visit the study participant portion of our website or contact us via email at email@example.com or telephone at +1 (866) 308-7427.